{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:07:37Z","timestamp":1767827257036,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1757-2215-7-18","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T04:01:31Z","timestamp":1391745691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Association between circulating adiponectin levels and polycystic ovarian syndrome"],"prefix":"10.1186","volume":"7","author":[{"given":"Saira Saeed","family":"Mirza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashif","family":"Shafique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Rauf","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masood","family":"Anwar Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,7]]},"reference":[{"key":"233_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/humupd\/dmp006","volume":"15","author":"KA Toulis","year":"2009","unstructured":"Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, et al.: Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 2009, 15: 297\u2013307. 10.1093\/humupd\/dmp006","journal-title":"Hum Reprod Update"},{"key":"233_CR2","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol 1961, 21: 1440\u20131447. 10.1210\/jcem-21-11-1440","journal-title":"J Clin Endocrinol"},{"key":"233_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.fertnstert.2007.01.032","volume":"88","author":"R Shroff","year":"2007","unstructured":"Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A: Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril 2007, 88: 1389\u20131395. 10.1016\/j.fertnstert.2007.01.032","journal-title":"Fertil Steril"},{"key":"233_CR4","first-page":"55","volume":"3","author":"LW Cho","year":"2007","unstructured":"Cho LW, Randeva HS, Atkin SL: Cardiometabolic aspects of polycystic ovarian syndrome. Vasc Health Risk Manag 2007, 3: 55\u201363.","journal-title":"Vasc Health Risk Manag"},{"key":"233_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0192623308329288","volume":"37","author":"Y Handelsman","year":"2009","unstructured":"Handelsman Y: Metabolic syndrome pathophysiology and clinical presentation. Toxicol Pathol 2009, 37: 18\u201320. 10.1177\/0192623308329288","journal-title":"Toxicol Pathol"},{"key":"233_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2217\/phe.09.69","volume":"4","author":"PM Vuguin","year":"2010","unstructured":"Vuguin PM: Interventional studies for polycystic ovarian syndrome in children and adolescents. Ped Health 2010, 4: 59\u201373. 10.2217\/phe.09.69","journal-title":"Ped Health"},{"key":"233_CR7","first-page":"58","volume":"29","author":"K Katulski","year":"2010","unstructured":"Katulski K, Meczekalski B: Natural history of polycyclic ovary syndrome. Pol Merkur Lekarski 2010, 29: 58\u201360.","journal-title":"Pol Merkur Lekarski"},{"key":"233_CR8","first-page":"636","volume":"27","author":"X Liu","year":"2010","unstructured":"Liu X, Zhang J, Li Y, Xu L, Wei D, Qiu D, et al.: On the relationship between serum total adiponectin and insulin resistance in polycystic ovary syndrome. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2010, 27: 636\u2013640.","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"key":"233_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000086273","volume":"60","author":"J Vrbikova","year":"2005","unstructured":"Vrbikova J, Dvorakova K, Hill M, Vcelak J, Stanicka S, Vankova M, et al.: Determinants of circulating adiponectin in women with polycystic ovary syndrome. Gynecol Obstet Invest 2005, 60: 155\u2013161. 10.1159\/000086273","journal-title":"Gynecol Obstet Invest"},{"key":"233_CR10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al.: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7: 941\u2013946. 10.1038\/90984","journal-title":"Nat Med"},{"key":"233_CR11","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","volume":"86","author":"C Weyer","year":"2001","unstructured":"Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al.: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86: 1930\u20131935. 10.1210\/jcem.86.5.7463","journal-title":"J Clin Endocrinol Metab"},{"key":"233_CR12","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.fertnstert.2007.04.046","volume":"89","author":"V Aroda","year":"2008","unstructured":"Aroda V, Ciaraldi TP, Chang SA, Dahan MH, Chang RJ, Henry RR: Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action. Fertil Steril 2008, 89: 1200\u20131208. 10.1016\/j.fertnstert.2007.04.046","journal-title":"Fertil Steril"},{"key":"233_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1210\/jc.2005-2153","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R: Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 2006, 91: 781\u2013785. 10.1210\/jc.2005-2153","journal-title":"J Clin Endocrinol Metab"},{"key":"233_CR14","volume-title":"The Asia-pacific perspective: redefining obesity and its treatment. Health communications Australia","author":"World Health Organization-International Obesity Task Force","year":"2000","unstructured":"World Health Organization-International Obesity Task Force: The Asia-pacific perspective: redefining obesity and its treatment. Health communications Australia. 2000."},{"key":"233_CR15","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovarian syndrome. Fertil Steril 2004, 81: 19\u201325.","journal-title":"Fertil Steril"},{"key":"233_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412\u2013419. 10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"233_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3949\/ccjm.77a.08079","volume":"77","author":"S Harrison","year":"2010","unstructured":"Harrison S, Somani N, Bergfeld WF: Update on the management of hirsutism. Cleve Clin J Med 2010, 77: 388\u201398. 10.3949\/ccjm.77a.08079","journal-title":"Cleve Clin J Med"},{"key":"233_CR18","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.fertnstert.2004.11.077","volume":"83","author":"MS Ardawi","year":"2005","unstructured":"Ardawi MS, Rouzi AA: Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2005, 83: 1708\u20131716. 10.1016\/j.fertnstert.2004.11.077","journal-title":"Fertil Steril"},{"key":"233_CR19","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1210\/jc.2007-2759","volume":"93","author":"TM Barber","year":"2008","unstructured":"Barber TM, Hazell M, Christodoulides C, Golding SJ, Alvey C, Burling K, et al.: Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition. J Clin Endocrinol Metab 2008, 93: 2859\u20132865. 10.1210\/jc.2007-2759","journal-title":"J Clin Endocrinol Metab"},{"key":"233_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/eje.1.01868","volume":"152","author":"E Carmina","year":"2005","unstructured":"Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM, et al.: Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005, 152: 389\u2013394. 10.1530\/eje.1.01868","journal-title":"Eur J Endocrinol"},{"key":"233_CR21","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1093\/humrep\/del146","volume":"21","author":"HF Escobar-Morreale","year":"2006","unstructured":"Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Alvarez-Blasco F, Sanchon R, Luque-Ramirez M, et al.: Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod 2006, 21: 2257\u20132265. 10.1093\/humrep\/del146","journal-title":"Hum Reprod"},{"key":"233_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jsgi.2004.09.003","volume":"12","author":"V Sepilian","year":"2005","unstructured":"Sepilian V, Nagamani M: Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. J Soc Gynecol Investig 2005, 12: 129\u2013134. 10.1016\/j.jsgi.2004.09.003","journal-title":"J Soc Gynecol Investig"},{"key":"233_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.metabol.2010.02.019","volume":"60","author":"EP Wickham III","year":"2011","unstructured":"Wickham EP III, Cheang KI, Clore JN, Baillargeon JP, Nestler JE: Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome. Metabolism 2011, 60: 366\u201372. 10.1016\/j.metabol.2010.02.019","journal-title":"Metabolism"},{"key":"233_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/diacare.24.1.89","volume":"24","author":"C Weyer","year":"2001","unstructured":"Weyer C, Tataranni PA, Bogardus C, Pratley RE: Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 2001, 24: 89\u201394. 10.2337\/diacare.24.1.89","journal-title":"Diabetes Care"},{"key":"233_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1210\/jc.2009-1985","volume":"95","author":"N Agarwal","year":"2010","unstructured":"Agarwal N, Rice SP, Bolusani H, Luzio SD, Dunseath G, Ludgate M, et al.: Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab 2010, 95: 722\u2013730. 10.1210\/jc.2009-1985","journal-title":"J Clin Endocrinol Metab"},{"key":"233_CR26","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1210\/jc.2008-0115","volume":"93","author":"K Elkind-Hirsch","year":"2008","unstructured":"Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R: Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008, 93: 2670\u20132678. 10.1210\/jc.2008-0115","journal-title":"J Clin Endocrinol Metab"},{"key":"233_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/eje.1.02331","volume":"156","author":"A Majuri","year":"2007","unstructured":"Majuri A, Santaniemi M, Rautio K, Kunnari A, Vartiainen J, Ruokonen A, et al.: Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. Eur J Endocrinol 2007, 156: 263\u2013269. 10.1530\/eje.1.02331","journal-title":"Eur J Endocrinol"},{"key":"233_CR28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2265.2007.03015.x","volume":"68","author":"D Glintborg","year":"2008","unstructured":"Glintborg D, Frystyk J, Hojlund K, Andersen KK, Henriksen JE, Hermann AP, et al.: Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome. Clin Endocrinol (Oxf) 2008, 68: 165\u2013174.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"233_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1365-2265.1998.00492.x","volume":"49","author":"DA Rodin","year":"1998","unstructured":"Rodin DA, Bano G, Bland JM, Taylor K, Nussey SS: Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin Endocrinol (Oxf) 1998, 49: 91\u201399. 10.1046\/j.1365-2265.1998.00492.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"233_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/humupd\/7.1.3","volume":"7","author":"PG Crosignani","year":"2001","unstructured":"Crosignani PG, Nicolosi AE: Polycystic ovarian disease: heritability and heterogeneity. Hum Reprod Update 2001, 7: 3\u20137. 10.1093\/humupd\/7.1.3","journal-title":"Hum Reprod Update"},{"key":"233_CR31","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1210\/jc.2007-1036","volume":"92","author":"T Sir-Petermann","year":"2007","unstructured":"Sir-Petermann T, Maliqueo M, Codner E, Echiburu B, Crisosto N, Perez V, et al.: Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007, 92: 4637\u20134642. 10.1210\/jc.2007-1036","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1757-2215-7-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T02:10:06Z","timestamp":1716516606000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/1757-2215-7-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["233"],"URL":"https:\/\/doi.org\/10.1186\/1757-2215-7-18","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,7]]},"assertion":[{"value":"28 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}